CRISPR/cas9 genome editing is used to introduce a T416K (AAC to AAG) mutation to exon 12 to modify residues near the putative channel pore. A silent mutation was also added to create a Dde1 restriction enzyme site. The mutation is homologous to the pathogenic human T422K mutation. (J:306425)